Trial intelligence / Profile preview

Temozolomide with Radiation for Brain Metastases from Breast Cancer

NCT00875355Phase 2Unknown

Sponsor
Institut Curie
Start
Nov 2007
Primary completion
Nov 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of temozolomide in breast cancer, sponsored by Institut Curie. Status: unknown.

02

Drugs

temozolomide
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00875355.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00875355.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call